Laure Elens1, Jean-Baptiste Woillard2, Michael Neely3, Arnaud Capron4, Ron Van Schaik5, Teun van Gelder6, Dennis Hesselink7, Nuria Lloberas8, Pierre Marquet9, Vincent Haufroid10 (1.Universite catholique de Louvain, 2.CHU limoges, 3.Children’s Hospital Los Angeles, 4.Universite catholique de Louvain, 5.University Medical Centre Rotterdam, 6.University Medical Center Rotterdam, 7.University Medical Center Rotterdam, 8.University of Barcelona, 9.CHU Limoges, 10.Universite catholique de Louvain)
Session information
Oral
[O26-3] O26-3: Pharmacogenomics (1)
Tue. Sep 26, 2017 3:00 PM - 4:00 PM Room C1 (1F)
Chairs: Ichiro Ieiri, Japan / Vincent Haufroid, Belgium
Tester F. Ashavaid1, Minal U. Paradkar2, Swarup A. Shah3, Alpa J. Dherai4, Dhanashree Shetty5 (1.Hinduja National Hospital & Medical Research Center, 2.Hinduja National Hospital & Medical Research Center, 3.Hinduja National Hospital & Medical Research Center, 4.Hinduja National Hospital & Medical Research Center, 5.Hinduja National Hospital & Medical Research Center)
[O26-3-3] DPYD polymorphisms and fluoropyrimidine toxicity — a single institution case control study
Nada Bozina1, Ivan Bilic2, Stjepko Plestina3, Damir Vrbanec4, Marko Kralik5, Lana Ganoci6 (1.University of Zagreb, 2.Universiti Hospital Centre Zagreb, 3.Universiti Hospital Centre Zagreb, 4.Universiti Hospital Centre Zagreb, 5.Universiti Hospital Centre Zagreb, 6.Universiti Hospital Centre Zagreb)
Pavithran Keechilat1, Arun Philip2, Akhila Sivadas3, Judith Mary Hariprakash4, Aradhana A.5, Akhilesh Kumar Sonakar6, Vinod Scaria7 (1.Amrita Insitute of Medical Sciences, 2.Amrita Insitute of Medical Sciences, 3.Amrita Insitute of Medical Sciences, 4.CSIR Institute of Genomics and Integrative Biology, 5.CSIR Institute of Genomics and Integrative Biology, 6.CSIR Institute of Genomics and Integrative Biology, 7.CSIR Institute of Genomics and Integrative Biology)